{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:12:59Z","timestamp":1781622779391,"version":"3.54.5"},"reference-count":45,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2016,4,11]]},"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the clinical and haemodynamic effects of carvedilol for patients with cirrhosis and portal hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>We searched PubMed, Cochrane library databases, EMBASE and the Science Citation Index Expanded through December 2015. Only randomised controlled trials (RCTs) were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measure<\/jats:title>\n                    <jats:p>We calculated clinical outcomes (all-cause mortality, bleeding-related mortality, upper gastrointestinal bleeding) as well as haemodynamic outcomes (hepatic venous pressure (HVPG) reduction, haemodynamic response rate, post-treatment arterial blood pressure (mean arterial pressure; MAP) and adverse events).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>12 RCTs were included. In 7 trials that looked at haemodynamic outcomes compared carvedilol versus propranolol, showing that carvedilol was associated with a greater reduction (%) of HVPG within 6\u2005months (mean difference \u22128.49, 95% CI \u221212.36 to \u22124.63) without a greater reduction in MAP than propranolol. In 3 trials investigating differences in clinical outcomes between carvedilol versus endoscopic variceal band ligation (EVL), no significant differences in mortality or variceal bleeding were demonstrated. 1 trial compared clinical outcomes between carvedilol versus nadolol plus isosorbide-5-mononitrate (ISMN), and showed that no significant difference in mortality or bleeding had been found. 1 trial comparing carvedilol versus nebivolol showed a greater reduction in HVPG after 14\u2005days follow-up in the carvedilol group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Carvedilol may be more effective in decreasing HVPG than propranolol or nebivolol and it may be as effective as EVL or nadolol plus ISMN in preventing variceal bleeding. However, the overall quality of evidence is low. Further large-scale randomised studies are required before we can make firm conclusions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>CRD42015020542.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2015-010902","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T20:33:39Z","timestamp":1462394019000},"page":"e010902","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":44,"title":["Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis"],"prefix":"10.1136","volume":"6","author":[{"given":"Tong","family":"Li","sequence":"first","affiliation":[{"name":"Hepatobiliary Surgery Centre, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Ke","sequence":"additional","affiliation":[{"name":"Hepatobiliary Surgery Centre, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Sun","sequence":"additional","affiliation":[{"name":"Hepatobiliary Surgery Centre, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Hepatobiliary Surgery Centre, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Belgaumkar","sequence":"additional","affiliation":[{"name":"HPB and Liver Transplant Surgery, Royal Free London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjian","family":"Huang","sequence":"additional","affiliation":[{"name":"Hepatobiliary Surgery Centre, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Xian","sequence":"additional","affiliation":[{"name":"Anesthesia Department, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Li","sequence":"additional","affiliation":[{"name":"Hepatobiliary Surgery Centre, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichang","family":"Zheng","sequence":"additional","affiliation":[{"name":"Hepatobiliary Surgery Centre, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,5,4]]},"reference":[{"key":"2025120619172341000_6.5.e010902.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.10.008"},{"key":"2025120619172341000_6.5.e010902.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0901512"},{"key":"2025120619172341000_6.5.e010902.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.06.004"},{"key":"2025120619172341000_6.5.e010902.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12778-X"},{"key":"2025120619172341000_6.5.e010902.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198810133191505"},{"key":"2025120619172341000_6.5.e010902.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044456"},{"key":"2025120619172341000_6.5.e010902.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70455-5"},{"key":"2025120619172341000_6.5.e010902.8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.09.013"},{"key":"2025120619172341000_6.5.e010902.9","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50133"},{"key":"2025120619172341000_6.5.e010902.10","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2012.666673"},{"key":"2025120619172341000_6.5.e010902.11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-304038"},{"key":"2025120619172341000_6.5.e010902.12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23775"},{"key":"2025120619172341000_6.5.e010902.13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.03.005"},{"key":"2025120619172341000_6.5.e010902.14","unstructured":"Higgins JPT , Green S . Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011."},{"key":"2025120619172341000_6.5.e010902.15","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-8-16"},{"key":"2025120619172341000_6.5.e010902.16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300124"},{"key":"2025120619172341000_6.5.e010902.17","unstructured":"Ren R , Zhang C . The comparison of recent curative effect on the reduction of hepatic vein pressure gradient in patients with cirrhosis (Master's thesis). 2012."},{"key":"2025120619172341000_6.5.e010902.18","unstructured":"Qu X , Zhang C . The preliminary research of the short-term reduction of hepatic vein pressure gradient to predict the long-term curative effect of beta-blockers (Master's thesis). 2012."},{"key":"2025120619172341000_6.5.e010902.19","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1080\/00365520600780403","article-title":"Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes","volume":"41","author":"Bruha","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"2025120619172341000_6.5.e010902.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2012.09.001"},{"key":"2025120619172341000_6.5.e010902.21","first-page":"299","article-title":"Effectiveness of beta blockers in primary prophylaxis of variceal bleeding in children with portal hypertension","volume":"32","author":"Samanta","year":"2011","journal-title":"Trop Gastroenterol"},{"key":"2025120619172341000_6.5.e010902.22","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/j.1572-0241.2004.40179.x","article-title":"Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis","volume":"99","author":"Lin","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"2025120619172341000_6.5.e010902.23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1440-1746.2002.02674.x","article-title":"Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics","volume":"17","author":"De","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"2025120619172341000_6.5.e010902.24","first-page":"467","article-title":"Acute and 14-day hepatic venous pressure gradient response to carvedilol and nebivolol in patients with liver cirrhosis","volume":"49","author":"Silkauskaite","year":"2013","journal-title":"Medicina (Kaunas)"},{"key":"2025120619172341000_6.5.e010902.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.11.019"},{"key":"2025120619172341000_6.5.e010902.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.06.015"},{"key":"2025120619172341000_6.5.e010902.27","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.36947"},{"key":"2025120619172341000_6.5.e010902.28","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23045"},{"key":"2025120619172341000_6.5.e010902.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2012.07244.x"},{"key":"2025120619172341000_6.5.e010902.30","first-page":"990a","article-title":"A randomized, multi-center, phase IV open-label study to evaluate and compare the effect of carvedilol versus propranolol on reduction in portal pressure in patients with cirrhosis: an interim analysis","volume":"58","author":"Sohn","year":"2013","journal-title":"Hepatology"},{"key":"2025120619172341000_6.5.e010902.31","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.11569\/wcjd.v22.i27.4146","article-title":"Short-term effect of carvedilol vs propranolol in reduction of hepatic venous pressure gradient in patients with cirrhotic portal hypertension. [Chinese]","volume":"22","author":"Mo","year":"2014","journal-title":"World Chin J Digestology"},{"key":"2025120619172341000_6.5.e010902.32","first-page":"278A","article-title":"A prospective, double-blind, randomized placebo-controlled trial of carvedilol for early primary prophylaxis of esophageal varices in cirrhosis","volume":"60","author":"Bhardwaj","year":"2014","journal-title":"Hepatology"},{"key":"2025120619172341000_6.5.e010902.33","first-page":"247","article-title":"The effects of carvedilol a nonselective beta-blocker on portal hemodynamics in cirrhosis","volume":"41","author":"Fierbinteanu-Braticevici","year":"2003","journal-title":"Rom J Intern Med"},{"key":"2025120619172341000_6.5.e010902.34","first-page":"278A","article-title":"A prospective, open labeled, randomized controlled trial comparing carvedilol+VSL#3 versus evl for primary prophylaxis of esophageal variceal bleeding in cirrhotic patients non-responder to carvedilol (NCT01196481)","volume":"60","author":"Bhardwaj","year":"2014","journal-title":"Hepatology"},{"key":"2025120619172341000_6.5.e010902.35","unstructured":"Demyen M . Carvedilol vs Band Ligation vs Combination Therapy for Primary Prophylaxis of Variceal Bleeding NCT02066649 . 2014. https:\/\/clinicaltrials.gov\/"},{"key":"2025120619172341000_6.5.e010902.36","unstructured":"Varea S . Study on b-blockers to prevent decompensation of cirrhosis with HTPortal (PREDESCI) NCT01059396 . 2010. https:\/\/clinicaltrials.gov\/"},{"key":"2025120619172341000_6.5.e010902.37","unstructured":"Chen S . The effect of carvedilol vs propranolol in cirrhotic patients with variceal bleeding NCT02385422 . 2015. https:\/\/clinicaltrials.gov\/"},{"key":"2025120619172341000_6.5.e010902.38","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12634"},{"key":"2025120619172341000_6.5.e010902.39","first-page":"961","article-title":"The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis","volume":"9","author":"Chen","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"2025120619172341000_6.5.e010902.40","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1665-2681(19)30849-X","article-title":"Hemodynamic effect of carvedilol vs. propranolol in cirrhotic patients: systematic review and meta-analysis","volume":"13","author":"Aguilar-Olivos","year":"2014","journal-title":"Ann Hepatol"},{"key":"2025120619172341000_6.5.e010902.41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2036.2002.01190.x","article-title":"Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension","volume":"16","author":"Tripathi","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"2025120619172341000_6.5.e010902.42","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301348"},{"key":"2025120619172341000_6.5.e010902.43","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.04.028"},{"key":"2025120619172341000_6.5.e010902.44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04075.x"},{"key":"2025120619172341000_6.5.e010902.45","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23689"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2015-010902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:17:33Z","timestamp":1765077453000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2015-010902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,4]]},"published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1136\/bmjopen-2015-010902"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2015-010902","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}